英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
tumpus查看　tumpus　在百度字典中的解释百度英翻中〔查看〕
tumpus查看　tumpus　在Google字典中的解释Google英翻中〔查看〕
tumpus查看　tumpus　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Tempus | AI-enabled precision medicine
    Tempus has built the world’s largest library of clinical molecular data and an operating system to make that data accessible and useful, starting with cancer
  • Tempus | Hub Access
    With access to the Tempus Hub, you’ll gain powerful tools to enhance patient care and streamline workflows—all within a secure platform Order and Manage Results : Easily order tests and track real-time order status with an intuitive interface, including add-on test options
  • Tempus Completes Acquisition of Ambry Genetics
    Tempus AI, Inc (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has completed its acquisition of Ambry Genetics, a recognized leader in genetic testing that aims to improve health by understanding the relationship between genetics and disease
  • Genomic Profiling - Tempus
    At Tempus, we are changing the way precision oncology care is delivered By leveraging clinical and molecular data, we offer comprehensive genomic profiling services, including hereditary testing, minimal residual disease and monitoring, and therapy selection, transforming the way cancer is diagnosed and treated
  • Tempus Announces Preliminary Fourth Quarter and Full Year 2024 Results
    Tempus AI, Inc (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced select, preliminary, unaudited results for the fourth quarter and full year ended December 31, 2024 Full Year 2024 Select, Preliminary, Unaudited Financial Results
  • Providers - Tempus
    Tempus can help physicians healthcare providers make more informed treatment decisions, and provides opportunities for research collaborations Learn more
  • Patients - Tempus
    Tempus is here to help Our mission is to help make sure patients are on the right therapy at the right time, so they can live longer and healthier lives Through our testing, we provide your doctor with detailed information to help choose the right treatment path
  • Tempus One Introduces New GenAI Capabilities to Query Millions of . . .
    Tempus One, which initially launched in 2023, provides both physicians and researchers AI-enabled services that leverage generative AI to propel privacy-enabled, data-driven decision support in the clinic while simultaneously advancing research to bring new drugs to market
  • Q A: Harnessing AI with multimodal data to transform drug development
    In this Q A, Kate Sasser, Chief Scientific Officer at Tempus, explains how Tempus is utilizing real-world data (RWD) for novel target discovery, clinical trial optimization, translational research, and evidence generation
  • Tempus Reports Fourth Quarter and Full Year 2024 Results
    Tempus now expects full year 2025 revenue of approximately $1 24 billion for the consolidated Tempus and Ambry Genetics business, which represents approximately 79% annual growth, and Adjusted EBITDA of $5 million for full year 2025, an improvement of approximately $110 million over 2024





中文字典-英文字典  2005-2009